Marion Webb has been writing about medtech since 2017, specializing in covering buzzy segments such as robotic surgery, digital therapeutics and femtech with in-depth features and interviews with leading experts. Her role includes reporting live from industry events, moderating panel discussions and podcasts, tweeting breaking news and engaging KOLs to provide high-quality, business-critical content for Medtech Insight. Marion has been writing about health care issues for more than two decades. She was a long-time biotech reporter at the San Diego Business Journal, worked at Bloomberg News, and contributed to the Los Angeles County Medical Association’s Physician Magazine. Marion was born and raised in Germany, is fluent in German and conversational in Spanish. Off the job, she’s a competitive runner, avid cyclist and swimmer, and enjoys spending time with her domestic partner and her German Shorthair Pointer mix Cora.
Latest from Marion Webb
Medtech leaders expect dealmaking to rebound in 2026, but buyers are more selective. Buyers are focused on high-value assets, and AI must prove real clinical and commercial value.
AI in medtech has moved from “experimentation into expectation,” leaders from Dexcom, Boston Scientific and Ajax Health said at the LSI conference. The execs advised start-ups to focus on embedding AI thoughtfully for real solutions, listening to customer feedback, and instilling a learning culture.
Google spinout Verily has raised $300m to advance its AI-driven personalized healthcare platforms and become an independent company.
Numares Health bets on a metabolomics-based urine test to help doctors detect kidney transplantation rejection earlier than current biomarkers, which would allow doctors to intervene earlier in trying to save the transplanted organ.
Paradromics has launched a new academic-industry collaboration with leading brain-computer interface researchers at Stanford, Mass General, Pitt, UC Davis and Michigan aiming to translate BCI research into devices to help people with speech impairment, stroke and Parkinson’s.
During panel discussions at HIMSS 26 focusing on AI-based tech integration at health systems, tech leaders from Mass General Brigham, City of Hope, Vanderbilt University, and Philips, stressed that start-ups need to solve clinical problems that integrate into workflows and deliver ROIs quickly.